Working… Menu

Low Dose Metronomic Poly-chemotherapy for Metastatic CRC (LDMchemoCRC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02280694
Recruitment Status : Active, not recruiting
First Posted : October 31, 2014
Last Update Posted : July 24, 2018
Information provided by (Responsible Party):
HaEmek Medical Center, Israel